Onco-Innovations Limited (CVE:ONCO)

PRESS RELEASE

published on 02/04/2025 at 05:36, 1 year 3 months ago

Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities

Acquisition AI Technology Precision Oncology Onco-Innovations Inka Health
BRIEF

published on 01/30/2025 at 23:05, 1 year 3 months ago

Onco-Innovations' PNKP Inhibitors Display Potential in Cancer Therapy

Cancer Therapy Drug Resistance PNKP Inhibitors DNA Repair Chemo Enhancement
BRIEF

published on 01/30/2025 at 23:05, 1 year 3 months ago

Les inhibiteurs PNKP d'Onco-Innovations présentent un potentiel dans le traitement du cancer

Thérapie Contre Le Cancer Inhibiteurs De La PNKP Réparation De L'ADN Résistance Aux Médicaments Amélioration De La Chimio
PRESS RELEASE

published on 01/30/2025 at 23:00, 1 year 3 months ago

Onco-Innovations' Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair
Onco-Innovations announces breakthrough Technology enhancing cancer treatment efficacy by inhibiting DNA repair in cancer cells, potentially improving patient outcomes in a multi-billion-dollar market

Patient Outcomes Cancer Treatment Onco-Innovations DNA Repair Inhibitors Cancer Therapy Market
BRIEF

published on 01/29/2025 at 22:50, 1 year 3 months ago

Onco-Innovations' Private Placement Fully Subscribed

Private Placement Securities Market Confidence Onco-Innovations Fully Subscribed
BRIEF

published on 01/29/2025 at 22:50, 1 year 3 months ago

Le placement privé d'Onco-Innovations est entièrement souscrit

Placement Privé Titres Confiance Du Marché Innovations Oncologiques Entièrement Abonné
PRESS RELEASE

published on 01/29/2025 at 22:45, 1 year 3 months ago

Onco-Innovations' Private Placement Fully Subscribed
Onco-Innovations Limited announces the full subscription of its non-brokered private placement, closing soon. Investors show strong confidence in the company's vision and mission in cancer research and treatment

Private Placement Investors Closing Date Cancer Research Onco-Innovations Limited
BRIEF

published on 01/24/2025 at 17:20, 1 year 3 months ago

Onco-Innovations Reports No Material Changes Amid Market Activity

Forward-looking Statements Cancer Research Market Activity Onco-Innovations Material Change
BRIEF

published on 01/24/2025 at 17:20, 1 year 3 months ago

Onco-Innovations ne signale aucun changement important malgré l'activité du marché

Énoncés Prospectifs Activité Du Marché Recherche Sur Le Cancer Innovations Oncologiques Changement De Matériau
PRESS RELEASE

published on 01/24/2025 at 17:15, 1 year 3 months ago

Onco-Innovations Unaware of Any Material Change
Onco-Innovations Limited addresses recent market activity, confirming no material changes. The Canadian company focuses on cancer research and treatment with innovative therapies

Innovative Solutions Cancer Research Market Activity Canadian Company Onco-Innovations Limited

Published on 05/17/2026 at 15:20, 6 hours 12 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 1 day 20 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 1 day 20 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 1 day 21 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 22 hours ago

Golden Minerals Reports First Quarter 2026 Financial Results

View all ACCESSWIRE

Published on 05/16/2026 at 16:08, 1 day 5 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 1 hour ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 2 days 3 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 2 days 3 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 2 days 3 hours ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

View all EQS

Published on 05/15/2026 at 15:08, 2 days 6 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 6 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 11 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 12 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 3 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE

News